Physician profile
Mark A Giovanini
NPI 1104833524
$31,831.19
in general payments reported to CMS, 2019-2025
11 companies · $517 in 2025
The $517 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $8,839 · 2021: $4,148 · 2022: $1,858 · 2023: $2,952 · 2024: $362 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,735 · Food and Beverage: $1,097.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,734.53 |
| Food and Beverage | $1,096.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $21,952.06 | 2019-2020 | |
| Medtronic, INC. | $4,537.23 | 2021-2025 | Anatomic Peek Ptc Cervical Fusion System, Adaptix Interbody System With Titan Nanolock Surface Technology, Rialto Si Fusion System |
| Si-Bone, INC. | $3,555.34 | 2021-2024 | |
| Aesculap Implant Systems, LLC | $1,196.81 | 2022 | |
| Nevro Corp. | $175.92 | 2024 | Senza |
| Globus Medical, INC. | $151.83 | 2025 | Vyrsa V1, Senza |
| Xtant Medical INC | $129.46 | 2025 | |
| Surgalign Spine Technologies, INC. | $46.17 | 2022 | |
| Baxter Healthcare | $41.98 | 2019 | |
| Abbvie INC. | $24.62 | 2023 | |
| Nalu Medical, INC. | $19.77 | 2025 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Giovanini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.